148 related articles for article (PubMed ID: 31890730)
1. rAAVrh74.MCK.
Zygmunt DA; Xu R; Jia Y; Ashbrook A; Menke C; Shao G; Yoon JH; Hamilton S; Pisharath H; Bolon B; Martin PT
Mol Ther Methods Clin Dev; 2019 Dec; 15():305-319. PubMed ID: 31890730
[TBL] [Abstract][Full Text] [Related]
2. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
[TBL] [Abstract][Full Text] [Related]
3. rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart.
Xu R; Jia Y; Zygmunt DA; Martin PT
Mol Ther; 2019 Mar; 27(3):636-649. PubMed ID: 30711447
[TBL] [Abstract][Full Text] [Related]
4. Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.
Chicoine LG; Rodino-Klapac LR; Shao G; Xu R; Bremer WG; Camboni M; Golden B; Montgomery CL; Shontz K; Heller KN; Griffin DA; Lewis S; Coley BD; Walker CM; Clark KR; Sahenk Z; Mendell JR; Martin PT
Mol Ther; 2014 Apr; 22(4):713-24. PubMed ID: 24145553
[TBL] [Abstract][Full Text] [Related]
5. B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.
Thomas PJ; Xu R; Martin PT
Am J Pathol; 2016 Sep; 186(9):2429-48. PubMed ID: 27561302
[TBL] [Abstract][Full Text] [Related]
6. An Isolated Limb Infusion Method Allows for Broad Distribution of rAAVrh74.MCK.
Xu R; Jia Y; Zygmunt DA; Cramer ML; Crowe KE; Shao G; Maki AE; Guggenheim HN; Hood BC; Griffin DA; Peterson E; Bolon B; Cheatham JP; Cheatham SL; Flanigan KM; Rodino-Klapac LR; Chicoine LG; Martin PT
Mol Ther Methods Clin Dev; 2018 Sep; 10():89-104. PubMed ID: 30073180
[TBL] [Abstract][Full Text] [Related]
7. A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.
Flanigan KM; Vetter TA; Simmons TR; Iammarino M; Frair EC; Rinaldi F; Chicoine LG; Harris J; Cheatham JP; Cheatham SL; Boe B; Waldrop MA; Zygmunt DA; Packer D; Martin PT
Mol Ther Methods Clin Dev; 2022 Dec; 27():47-60. PubMed ID: 36186954
[TBL] [Abstract][Full Text] [Related]
8. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
[TBL] [Abstract][Full Text] [Related]
9. Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.
Cramer ML; Shao G; Rodino-Klapac LR; Chicoine LG; Martin PT
Hum Gene Ther; 2017 Jun; 28(6):493-509. PubMed ID: 28345428
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
Xu R; DeVries S; Camboni M; Martin PT
Am J Pathol; 2009 Jul; 175(1):235-47. PubMed ID: 19498002
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A.
Xu R; Chandrasekharan K; Yoon JH; Camboni M; Martin PT
Am J Pathol; 2007 Jul; 171(1):181-99. PubMed ID: 17591965
[TBL] [Abstract][Full Text] [Related]
12. Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of
Cramer ML; Xu R; Martin PT
Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036568
[No Abstract] [Full Text] [Related]
13. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling.
Chandraskeharan K; Martin PT
Muscle Nerve; 2009 Jan; 39(1):25-41. PubMed ID: 19086062
[TBL] [Abstract][Full Text] [Related]
14. Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.
Xu R; Camboni M; Martin PT
Neuromuscul Disord; 2007 Mar; 17(3):209-20. PubMed ID: 17300937
[TBL] [Abstract][Full Text] [Related]
15. Development of Assays to Measure GNE Gene Potency and Gene Replacement in Skeletal Muscle.
Zygmunt DA; Lam P; Ashbrook A; Koczwara K; Lek A; Lek M; Martin PT
J Neuromuscul Dis; 2023; 10(5):797-812. PubMed ID: 37458043
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy.
Goedeker NL; Dharia SD; Griffin DA; Coy J; Truesdale T; Parikh R; Whitehouse K; Santra S; Asher DR; Zaidman CM
Ther Adv Neurol Disord; 2023; 16():17562864221149781. PubMed ID: 36710722
[TBL] [Abstract][Full Text] [Related]
17. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy for muscular dystrophy].
Takeda S
No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy.
Zygmunt DA; Crowe KE; Flanigan KM; Martin PT
Hum Gene Ther; 2017 Sep; 28(9):737-746. PubMed ID: 28042944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
